Sprint Bioscience AB (publ)

OM:SPRINT Stock Report

Market Cap: SEK 96.4m

Sprint Bioscience Balance Sheet Health

Financial Health criteria checks 6/6

Sprint Bioscience has a total shareholder equity of SEK18.7M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK48.3M and SEK29.6M respectively. Sprint Bioscience's EBIT is SEK14.3M making its interest coverage ratio -12.1. It has cash and short-term investments of SEK36.0M.

Key information

0%

Debt to equity ratio

SEK 0

Debt

Interest coverage ratio-12.1x
CashSEK 36.01m
EquitySEK 18.69m
Total liabilitiesSEK 29.61m
Total assetsSEK 48.30m

Recent financial health updates

Recent updates

Estimating The Fair Value Of Sprint Bioscience AB (publ) (STO:SPRINT)

Jun 12
Estimating The Fair Value Of Sprint Bioscience AB (publ) (STO:SPRINT)

A Look At The Intrinsic Value Of Sprint Bioscience AB (publ) (STO:SPRINT)

Feb 19
A Look At The Intrinsic Value Of Sprint Bioscience AB (publ) (STO:SPRINT)

Is Sprint Bioscience (STO:SPRINT) In A Good Position To Deliver On Growth Plans?

Nov 19
Is Sprint Bioscience (STO:SPRINT) In A Good Position To Deliver On Growth Plans?

Financial Position Analysis

Short Term Liabilities: SPRINT's short term assets (SEK43.7M) exceed its short term liabilities (SEK29.6M).

Long Term Liabilities: SPRINT has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: SPRINT is debt free.

Reducing Debt: SPRINT had no debt 5 years ago.

Debt Coverage: SPRINT has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: SPRINT has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies